Skip to main content
WST logo

West Pharmaceutical Services Inc

Exchange: NYSESector: HealthcareIndustry: Medical Instruments & Supplies

West Pharmaceutical Services, Inc. (West) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. Its business operations are organized into two segments: Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems). Its products include stoppers and seals for vials, prefillable syringe components and systems, components for intravenous and blood collection systems, safety and administration systems, advanced injection systems, and contract design and manufacturing services. Its customers include the global producers and distributors of pharmaceuticals, biologics, medical devices and personal care products.

Did you know?

Price sits at 63% of its 52-week range.

Current Price

$267.93

+3.07%

GoodMoat Value

$166.89

37.7% overvalued
Profile
Valuation (TTM)
Market Cap$19.28B
P/E39.04
EV$16.90B
P/B6.07
Shares Out71.94M
P/Sales6.27
Revenue$3.07B
EV/EBITDA23.89

West Pharmaceutical Services Inc (WST) Stock Chart

WST

WST Chart

Loading chart data…

WST Interactive Stock Chart

Interactive stock chart for West Pharmaceutical Services Inc (WST) with candlestick and line chart views. Analyze price action across multiple timeframes: 5 days, 1 week, 1 month, 3 months, 6 months, 1 year, 5 years, and full history.

Current price: $267.93. 52-week high: $306.72. 52-week low: $201.18. 50-day moving average: $246.28. 200-day moving average: $254.75.

Technical analysis indicators include Volume, SMA 20, SMA 50, SMA 200, EMA 20, and RSI. Toggle between candlestick and line chart styles. Overlay multiple moving averages to identify support and resistance levels, trend direction, and momentum signals for WST. Use the chart alongside GoodMoat's fundamental analysis tools for a complete picture of West Pharmaceutical Services Inc's investment potential.